Reka twige ku ndwara ya DLBCL (Diffuse Large B-Cell Lymphoma) mu buryo bworoshye.

Wigeze wumva indwara ya `Diffuse Large B-Cell Lymphoma` cyangwa `DLBCL`? Iyi ni ubwoko bwa kanseri ikwirakwira vuba. Ariko ntugahangayike, iyo igaragaye hakiri kare ikavurwa neza , irashobora gukira . Uyu munsi, reka tuganire kuri iyi `DLBCL` mu magambo make.

DLBCL ni iki?

DLBCL ni kanseri y'amaraso. Muri iyi ndwara, ubwoko bw'uturemangingo tw'amaraso twera twitwa B cells (nanone twitwa lymphocytes) mu mubiri wacu burahinduka kanseri. Ubu ni bwo bwoko bwa lymphoma bukunze kugaragara, bukura vuba, kandi bukabije bwitwa non-Hodgkin lymphoma. Sisitemu yacu ya lymphatic irwanya mikorobe. Iyo DLBCL ikuze, izi selile za B ziba kanseri kandi zigakura vuba, zigatuma uturemangingo tuzima tubura. Hanyuma ntizishobora kurwanya mikorobe. Izi selile za kanseri zishobora kubaho ahantu hose, harimo n'uturemangingo tw'amaraso, inzira y'igogora, n'ubwonko. Nubwo ari ikibazo gikomeye, gishobora gukira iyo kibonetse hakiri kare.

Ni ubuhe bwoko bwa DLBCL?

Umuryango Mpuzamahanga wita ku Buzima (OMS) wagaragaje ubwoko butandukanye bwa DLBCL. Abaganga bakoresha buri bwoko kugira ngo bamenye uko kanseri itera imbere n'uko yakira iyo ivuwe. Ubu bwoko bushingiye ahanini kuri ibi bikurikira:

• Impinduka mu ngirabuzimafatizo .
• Aho DLBCL itangirira mu mubiri (urugero: uturemangingo tw'imitsi - `CNS`).
• Ihuriro na virusi (urugero: virusi ya Epstein-Barr - EBV).

Ni ngombwa cyane kubaza muganga wawe ubwoko bwa DLBCL ufite.

Ibi ni ibisanzwe gute?

DLBCL ni yo ndwara ikunze kugaragara cyane ya lymphoma. Ariko, DLBCL ntabwo ikunze kugaragara cyane muri kanseri muri rusange. Urugero, DLBCL igaragara ku bantu bagera kuri 6 ku 100.000. Ibi ni gake cyane ugereranyije n'izindi kanseri.

Ni ibihe bimenyetso bya DLBCL?

Ikimenyetso gikunze kugaragara cya DLBCL ni ukubyimba kw'uturemangingo tw'imitsi mu ijosi, mu kwaha, cyangwa mu kibuno . Ibi bishobora gutangira nk'ikibyimba, bikagenda bikura buhoro buhoro, kandi ntibibabaze.

Hari abantu bamwe (hafi umwe muri batatu) bashobora kugira ibimenyetso byihariye byitwa "ibimenyetso bya B" :

• Umuriro (uri hejuru ya selisiyusi 39.5) umara iminsi irenga ibiri cyangwa ukagenda.
• Kugabanya ibiro birenga 10% by'umubiri mu mezi atandatu nta mpamvu iyo ari yo yose.
• Kubira ibyuya byinshi nijoro, ku buryo amashuka atangira kunyagirwa.

Ntutinye gutekereza ko ari DLBCL nubwo waba ufite ibi bimenyetso. Ariko, niba bikomeje mu byumweru byinshi, gana muganga.

Kuki DLBCL ikura? Ni ibihe bintu bishobora gutera ibyago?

DLBCL iterwa n'impinduka mu turemangingo twa B. Izi ni impinduka mu turemangingo ziba mu buzima . Impamvu nyayo ntabwo izwi, ariko hari ibintu byinshi byagaragaye byongera ibyago:

• Imyaka:Ikunze kugaragara cyane ku bantu bari mu kigero cy'imyaka 60. Impuzandengo y'imyaka yo gusuzuma iyi ndwara ni hafi imyaka 64.
• Igitsina: Abagabo bashobora gukura gato kurusha abagore.
• Amateka y'umuryango: Niba umuvandimwe wo mu rwego rwa mbere (umubyeyi, umuvandimwe, umwana) afite DLBCL, ushobora kugira ibyago byo kuyirwara (impamvu ntirasobanuka neza).
• Kwandura: Virusi nka virusi ya Epstein-Barr (EBV), virusi itera SIDA, na hepatite B na C.
• Ubudahangarwa bw'umubiri bugabanuka: Kugira ``indwara y'ibanze y'ubudahangarwa bw'umubiri`` cyangwa ``indwara y'ubwiyongere bw'umubiri``, cyangwa gufata ``imiti igabanya ubudahangarwa bw'umubiri`` nyuma yo guterwa urugingo. Iki ni ikintu gikomeye gishobora gutera ibyago.
• Uburemere bw'umubiri buri hejuru (BMI) akiri muto no guhura n'ibintu bimwe na bimwe by'uburozi bikoreshwa mu buhinzi.

Nubwo ibi bintu bibaho, si buri wese ubyiteza imbere, cyangwa se ashobora kubiteza imbere. Ariko ni ngombwa kubimenya.

DLBCL ipimwa ite? (Isuzuma)

Abaganga bemeza DLBCL binyuze mu gupima agace gato k'agace kabyimbye kameze nk'umusemburo (gufata agace gato k'agace kabyimbye kameze nk'umusemburo) no gupima imiterere y'uturemangingo. Iyo DLBCL yemejwe, hakorwa ibindi bizamini kugira ngo barebe niba kanseri yarakwirakwiriye:

• Gupima amaraso: Umubare wuzuye w'amaraso (CBC), kugira ngo harebwe virusi nka VIH, EBV, na hepatite.
• Ikizamini cya Lactate dehydrogenase (LDH): Iyi enzyme iboneka ku rugero rwo hejuru mu barwayi benshi ba DLBCL.
• Ibizamini byo gufata amashusho: CT scan, MRI scan, PET scan.
• `Isuzuma ry'umusemburo w'amagufwa` .
• Gutobora mu gituza (gusuzuma amazi yo mu ruti rw'umugongo).

Abaganga bafata ibyemezo ku bijyanye n'uburwayi bwawe kandi bagateganya uburyo bwo kuvura bashingiye ku makuru bakuye muri buri kizamini.

Ni ibihe byiciro bya DLBCL?

Uburyo bwo gupima kanseri bukoreshwa mu kumenya aho kanseri yakuriye n'aho yakwirakwiriye. Ibi bifasha mu gutegura uburyo bwo kuyivura no kumenya igihe izakwirakwira. Ibyiciro bya DLBCL ni ibi bikurikira:

• Icyiciro cya mbere: Kanseri iba mu gace kamwe gusa k’urugingo rwa lymphatic, igice kimwe cyo mu gice cy’urugingo rwa lymphatic, cyangwa agace kamwe k’urugingo rumwe ruri hanze y’urugingo rwa lymphatic.
• Icyiciro cya II: Lymphoma iboneka mu matsinda menshi y'uturemangingo tw'imitsi ku ruhande rumwe rwa diaphragm.
• Icyiciro cya gatatu: Kanseri iboneka mu tunyangingo tw’imitsi ku mpande zombi z’agace k’umuyoboro w’amaraso.
• Icyiciro cya kane:Kanseri ya DLBCL yakwirakwiriye mu ngingo zitari mu buryo bwa limfu (urugero: umwongo w'amagufwa, umwijima, ibihaha).

Abaganga bita icyiciro cya I n'icya II "intambwe za mbere" naho icyiciro cya III n'icya IV "intambwe ziteye imbere."

Ni ubuhe buryo bwo kuvura DLBCL?

Uburyo bukunze kuvura DLBCL ni R-CHOP . Ibi bikubiyemo guhuza antibody ya monoclonal yitwa rituximab, ubwoko butandukanye bwa chemotherapy, na corticosteroid. Nubwo ubu buryo bwaba bwiza, indwara ishobora kugaruka (hafi 30%-40%). Ibi nibibaho, muganga wawe ashobora kukugira inama y'ubundi buryo bwo kuvura:

• Uburyo bwa kabiri bwo kuvura no gusimbuza uturemangingo tw’umubiri twitwa "autologous stem cell".
• `Ubuvuzi bwa CAR T-cell`: Ubu ni `ubuvuzi bw'imyororokere`.
• `Ubuvuzi bwibanda ku mpinduka mu ngirabuzimafatizo`: Ubuvuzi bugamije impinduka mu ngirabuzimafatizo.

Wibuke ko muganga wawe azaguhitiramo uburyo bwiza bwo kuvura hashingiwe ku ndwara yawe.

Ese iterambere rya DLBCL rishobora kwirindwa?

Nta buryo bwo kwirinda burundu DLBCL. Hari ibintu bishobora gutuma tudashobora kugenzura. Ariko, hari intambwe dushobora gufata kugira ngo twirinde indwara zishobora kuba zifitanye isano na DLBCL, nka hepatite na virusi itera SIDA. Ni byiza kandi kugerageza kugumana igipimo cy’uburemere bw’umubiri (BMI) cyiza. Ibi bishobora kugufasha kugabanya ibyago byawe ku rugero runaka.

Ni iki umuntu urwaye DLBCL yakwitega?

Amwe mu moko ya DLBCL ashobora gushyira ubuzima mu kaga kandi akagorana kuyavura. Ariko, abaganga bakunze kuvura no kuyakiza . Kenshi na kenshi, ubuvuzi bw’ibanze bushobora gutuma DLBCL isubira neza (aho nta bimenyetso cyangwa ibimenyetso bya kanseri bihari). Abantu bagera kuri 60% barwaye DLBCL bakira hakoreshejwe ubuvuzi bw’ibanze. Ugereranyije, abantu badafite kanseri nyuma y’imyaka ibiri basanzwe barwaye bashobora kubaho ubuzima busanzwe, nk’ubw’abandi bantu bo mu kigero cyabo. Igipimo cyo kubaho kiba kinini kurushaho iyo kanseri igaragaye hakiri kare .

Ariko, ubunararibonye bwawe buzaterwa n'ibintu byinshi, harimo ubwoko bwa DLBCL ufite, icyiciro cya kanseri, n'ubuzima bwawe muri rusange. Muganga wawe ni we wenyine ushobora kuguha amakuru meza kuri ibi.

Niyitaho nte? (Kwiyitaho)

Kubana na kanseri ntabwo byoroshye, birananiza cyane. Ni ingenzi cyane kwiyitaho mu gihe uri kuvurwa `DLBCL`.

• Indyo: Kurya indyo yuzuye kandi yuzuye. Baza muganga wawe ibyo kurya n'ibyo kwirinda.
• Ikiruhuko:Kuvura bishobora gutera umunaniro. Shaka ikiruhuko gihagije.
• Imyitozo ngororamubiri: Imyitozo ngororamubiri yoroheje ishobora kugabanya stress.
• Ubufasha: Iyi ni indwara idakunze kugaragara, bityo ishobora kumva ifite irungu. Jya mu matsinda y'ubufasha aho hari abantu nkawe. Vugana n'umuryango n'inshuti.

Gukenera kubonana na muganga n'ibyihutirwa

Uzareba muganga wawe buri gihe mu gihe cyo kuvurwa. Ndetse na nyuma yo kuvura, uzakenera kumusura buri mezi 3-4 mu myaka ibiri ya mbere kandi ntugakore kenshi mu myaka itatu iri imbere. Ibi ni ukureba niba kanseri yongeye kugaruka. Niba ufite ibimenyetso byerekana ko kanseri yagarutse, bwira muganga wawe ako kanya.

Uburyo bwo kuvura nka chimiotherapie bushobora kugira ingaruka mbi zikomeye. Ibi nibibaho , jya mu cyumba cy’ubutabazi bwihuse :

• Ingaruka mbi zikomeye kurusha uko byari byitezwe.
• Umuriro uri hejuru ya selisiyusi 38 (100.4 Fahrenheit).
• Gutigita ku buryo budahagarara .
• Kubabara mu gifu cyane cyangwa impiswi idashira .

Ibibazo byo kubaza muganga wawe ku bijyanye na DLBCL

Ni ibisanzwe kugira ibibazo byinshi iyo umenye ko ufite DLBCL. Ni ngombwa ko ubaza muganga wawe ibibazo nk'ibi:

• Ni ubuhe bwoko bwa 'Diffuse Large B-Cell Lymphoma' mfite? 'Stage' ni iyihe?
• Ni ubuhe bwoko bw'ubuvuzi nkeneye? Ingaruka mbi ni izihe?
• Ese ubu buryo bwo kuvura bushobora kuvura kanseri burundu?
• Ni ubuhe buryo bwo kuvura buhari iyo kanseri igarutse?
• Ese ushobora kunyandikira itsinda rishinzwe gufasha abantu bafite ubwo bwoko bwa kanseri?

Uretse ibi bibazo, ntutinye kubaza muganga wawe ikintu icyo ari cyo cyose ufite mu mutwe cyangwa gushidikanya ushobora kuba ufite.

Amaherezo, ibuka (Ubutumwa bwo kujyana mu rugo)

Iyo abenshi muri twe twumva ijambo "aggressive" iyo tuvuga kanseri, tuyifata nk'indwara idakira kandi igoye kuyivura. Ariko si ko bimeze kuri Diffuse Large B-Cell Lymphoma (DLBCL). Nubwo DLBCL ishobora gukwirakwira vuba, uburyo bwo kuvura kanseri muri iki gihe bushobora kwica izi selile za B za kanseri. Abaganga banakoresha amagambo nka "treat" iyo bavuga ku ndwara zimwe na zimwe z'abantu.

Igikuru ni ukubaza muganga wawe uburyo indwara yawe izagira ingaruka ku buryo uvura. Rero, ntutinye, menya amakuru, kandi ukurikize inama za muganga wawe. Ntiwibagirwe ko DLBCL ishobora gutsindwa iyo uyibonye hakiri kare kandi ukayivura neza!

Kanseri , lymphoma, uturemangingo twa B, lymph nodes, ibimenyetso, uburyo bwo kuvura, DLBCL, chemotherapy, immunotherapy